| 2020 | Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study | GUT |
| 2020 | Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2020 | Predictive score for hepatocellular carcinoma after hepatitis B e antigen loss in patients treated with entecavir or tenofovir | JOURNAL OF VIRAL HEPATITIS |
| 2020 | Human liver CD8 + MAIT cells exert TCR/MR1-independent innate-like cytotoxicity in response to IL-15 | JOURNAL OF HEPATOLOGY |
| 2020 | Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2020 | Phase I Radiation Dose-Escalation Study to Investigate the Dose-Limiting Toxicity of Concurrent Intra-Arterial Chemotherapy for Unresectable Hepatocellular Carcinoma
| CANCERS |
| 2020 | Should physicians go out of the way to differentiate between acute hepatitis B and acute exacerbation of chronic hepatitis B?
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2020 | Cumulative Incidence of Hepatocellular Carcinoma and Hepatitis B Surface Antigen Seroclearance After Nucleos(t) Ide Analogue-Induced Hepatitis B E Antigen Seroclearance
| BMC GASTROENTEROLOGY |
| 2019 | 항바이러스 치료의 장기 효과: 사망 및 간암 발생 관련
| Korean Journal of Gastroenterology |
| 2019 | Aromatase Inhibitors and Newly Developed Nonalcoholic Fatty Liver Disease in Postmenopausal Patients with Early Breast Cancer: A Propensity Score-Matched Cohort Study | ONCOLOGIST |
| 2019 | Value of controlled attenuation parameter in fibrosis prediction in nonalcoholic steatohepatitis
| World Journal of Gastroenterology |
| 2019 | Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation
| Cancer Medicine |
| 2019 | Follow-Up Liver Stiffness Measurements after Liver Resection Influence Oncologic Outcomes of Hepatitis-B-Associated Hepatocellular Carcinoma with Liver Cirrhosis
| CANCERS |
| 2018 | 고령 환자의 간암치료 및 감시
| Journal of Liver Cancer (대한간암학회지) |
| 2018 | Selective deletion of hepatocyte platelet-derived growth factor receptor α and development of liver fibrosis in mice
| CELL COMMUNICATION AND SIGNALING |
| 2018 | Seroepidemiology of Hepatitis Viruses and Hepatitis B Genotypes of Female Marriage Immigrants in Korea.
| YONSEI MEDICAL JOURNAL |
| 2013 | Human liver carboxylesterase 1 outperforms alpha-fetoprotein as biomarker to discriminate hepatocellular carcinoma from other liver diseases in Korean patients | INTERNATIONAL JOURNAL OF CANCER |
| 2010 | Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B | HEPATOLOGY |
| 2009 | Recombinant interferon-Beta-1alpha plus ribavirin for the treatment of chronic HCV infection: a prospective, randomized, comparative pilot study
| GUT AND LIVER |
| 2009 | Rescue monotherapy in lamivudine-resistant hepatitis B e antigen-positive chronic hepatitis B: adefovir versus entecavir | ANTIVIRAL THERAPY |
| 2007 | 하대정맥 침습 또는 심방 종양혈전증을 보이는 진행 간세포암종의 임상 특징과 치료에 따른 예후
| Korean Journal of Hepatology (대한간학회지) |
| 2007 | Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinoma
| CANCER |
http://orcid.org/0000-0002-6958-3035
(55509204800)
